ES2497574T3 - Hidróxido carbonato de magnesio directamente compresible - Google Patents

Hidróxido carbonato de magnesio directamente compresible Download PDF

Info

Publication number
ES2497574T3
ES2497574T3 ES11700067.9T ES11700067T ES2497574T3 ES 2497574 T3 ES2497574 T3 ES 2497574T3 ES 11700067 T ES11700067 T ES 11700067T ES 2497574 T3 ES2497574 T3 ES 2497574T3
Authority
ES
Spain
Prior art keywords
magnesium carbonate
twenty
directly compressible
carbonate hydroxide
compressible magnesium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11700067.9T
Other languages
English (en)
Inventor
Marianne Dohmen
Ralf Fiedler
Heike Mueller
Jens Klatyk
Hans-Kurt Peth
Guenter Moddelmog
Thorsten Wedel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Application granted granted Critical
Publication of ES2497574T3 publication Critical patent/ES2497574T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F5/00—Compounds of magnesium
    • C01F5/24—Magnesium carbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00—Particle morphology
    • C01P2004/60—Particles characterised by their size
    • C01P2004/61—Micrometer sized, i.e. from 1-100 micrometer
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/11—Powder tap density
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/12—Surface area
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/21—Attrition-index or crushing strength of granulates
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Geology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Dental Preparations (AREA)

Abstract

Hidróxido carbonato de magnesio directamente compresible (pesado conforme a los requisitos de PhEur, BP, USP y E 504) caracterizado por que presenta una superficie BET de al menos 44 hasta 70 m2/g, una densidad aparente de 0,40 hasta 0,60 g/mI y una densidad aparente compactada de 0,50 hasta 0,80 g/mI.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
E11700067
29-08-2014
(continuación)
Muestra
Fuerza de compresión [kN] Teórico Real Dureza de comprimido día 1 [N] Friabilidad [%]
C
5 5,9 103,8 0,01
10
10,1 189,3 0,01
20
19,2 361,2 0
30
32,1 491,6 0
D
5 5,4 88,1 0,11
10
10,5 194,7 0
20
20,4 415,9 0
30
30,4 492,2 0
E
5 5,5 61,0 0,66
10
11,7 124,5 0,07
20
21,2 238,0 0
30
30,7 419,1 0
F
5 ¡Debido a las propiedades de flujo deficientes no es posible
10
prensar!
20
30
G
5 5,2 15,1 6,92
10
10,1 39,9 1,20
20
20,4 120,2 0,22
30
31,0 269,9 0,11
H
5 5,0 24,2 3,70
10
10,5 59,1 0,34
20
20,8 158,6 0,08
30
31,0 290,5 0,04
Tabla 5:
Muestra
Fuerza de compresión [kN] Teórico Real Dureza de comprimido día 1 [N] Friabilidad [%]
A
5 10 20 30 5,4 10,6 21,3 31,0 52,0 124,6 321,5 457,0 0,92 0,14 0,06 0,01
B
5 10 20 30 4,6 9,9 20,6 29,8 37,6 88,3 272,9 397,1 1,11 0,05 0 0
12
E11700067
29-08-2014
(continuación)
Muestra
Fuerza de compresión [kN] Teórico Real Dureza de comprimido día 1 [N] Friabilidad [%]
C
5 5,9 103,8 0,01
10
10,1 189,3 0,01
20
19,2 361,2 0
30
32,1 491,6 0
D
5 5,4 88,1 0,11
10
10,5 194,7 0
20
20,4 415,9 0
30
30,4 492,2 0
E
5 5,5 61,0 0,66
10
11,7 124,5 0,07
20
21,2 238,0 0
30
30,7 419,1 0
F
5 ¡Debido a las propiedades de flujo deficientes no es posible
10
prensar!
20
30
I
5 5,4 39,4 0,47
10
10,5 92,0 0,07
20
20,3 207,4 0,01
30
29,8 329,5 0,08
K
5 4,8 58,9 0,16
10
10,4 139,5 0,09
20
20,7 268,3 0,06
30
28,3 329,3 0,08
L
5 4,7 56,5 0,18
10
9,2 121,5 0,11
20
20,4 267,5 0,08
30
30,4 350,8 0,05
5 Calidades comerciales utilizadas para los ensayos comparativos de artículos en polvo, así como hidróxido carbonatos de magnesio directamente compresibles, pesados:
F: Hidróxido carbonato de magnesio, pesado, puro, Ph EUR, BP, USP, E 504, Merck KGaA, Darmstadt [Alemania], Art. Nº. 1.05829, lote K38796529 (se trata de un artículo en polvo sin las propiedades de compresión directa prometidas)
10 G: Carbonato de magnesio directamente compresible pesado NutriMag MC, calidad farmacéutica, granulado, con pureza conforme a BP, USP, Ph.Eur, CALMAGS GmbH, Lüneburg [Alemania], lote: 308075060
13
imagen11

Claims (1)

  1. imagen1
    imagen2
ES11700067.9T 2010-02-03 2011-01-07 Hidróxido carbonato de magnesio directamente compresible Active ES2497574T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10001099 2010-02-03
EP10001099 2010-02-03
PCT/EP2011/000045 WO2011095269A2 (de) 2010-02-03 2011-01-07 Direkt verpressbares magnesiumhydroxidcarbonat

Publications (1)

Publication Number Publication Date
ES2497574T3 true ES2497574T3 (es) 2014-09-23

Family

ID=44355853

Family Applications (1)

Application Number Title Priority Date Filing Date
ES11700067.9T Active ES2497574T3 (es) 2010-02-03 2011-01-07 Hidróxido carbonato de magnesio directamente compresible

Country Status (10)

Country Link
US (1) US20120301520A1 (es)
EP (1) EP2531178B1 (es)
JP (1) JP5926195B2 (es)
CA (1) CA2788740C (es)
DK (1) DK2531178T3 (es)
ES (1) ES2497574T3 (es)
HR (1) HRP20140757T1 (es)
PL (1) PL2531178T3 (es)
PT (1) PT2531178E (es)
WO (1) WO2011095269A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150273062A1 (en) * 2012-09-18 2015-10-01 Merck Patent Gmbh Magnesium hydroxide carbonate as carrier material in active ingredient-containing preparations
BR112015014739A2 (pt) * 2012-12-21 2017-07-11 Merck Patent Gmbh carbonato hidróxido de magnésio como excipiente em preparações farmacêuticas tendo liberação melhorada do ingrediente ativo
JP6194253B2 (ja) * 2014-01-20 2017-09-06 神島化学工業株式会社 水酸化マグネシウムの加圧粒状体、及びその製造方法
CN107735527A (zh) * 2015-01-14 2018-02-23 英默里斯美国公司 沉淀碳酸钙的受控方法和通过所述方法形成的球霰石沉淀碳酸钙组合物
CN107205387B (zh) * 2015-02-02 2020-11-13 默克专利股份有限公司 包含防虫剂的粉末配制剂
CN109721083A (zh) * 2019-01-07 2019-05-07 河北科技大学 一种无水碳酸镁的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422176A (en) * 1973-05-05 1976-01-21 Beecham Group Ltd Pharmaceutical tablets
JPS6054915A (ja) * 1983-09-01 1985-03-29 Tokuyama Soda Co Ltd 球状塩基性炭酸マグネシウム及びその製造方法
EP0460923B1 (en) * 1990-06-04 1994-12-28 Tokuyama Corporation Basic magnesium carbonate and process for preparation thereof
JPH04228420A (ja) * 1990-06-04 1992-08-18 Tokuyama Soda Co Ltd 塩基性炭酸マグネシウム及びその製造方法
JPH04369375A (ja) * 1991-06-17 1992-12-22 Matsushita Refrig Co Ltd 冷蔵庫
US5838571A (en) * 1996-01-29 1998-11-17 Alza Corporation Tablet press monitoring and controlling method and apparatus
JP3910495B2 (ja) * 2002-02-13 2007-04-25 日鉄鉱業株式会社 塩基性炭酸マグネシウム及びその製造方法、並びに該塩基性炭酸マグネシウムを含有する組成物又は構造体
RU2497503C9 (ru) * 2008-03-10 2014-09-20 Байер Конзюмер Кер АГ Приятная на вкус твердая композиция, включающая нейтрализатор кислотности и стимулятор слюноотделения

Also Published As

Publication number Publication date
CA2788740A1 (en) 2011-08-11
US20120301520A1 (en) 2012-11-29
PT2531178E (pt) 2014-09-12
EP2531178A2 (de) 2012-12-12
CA2788740C (en) 2017-09-12
PL2531178T3 (pl) 2014-11-28
HRP20140757T1 (hr) 2014-10-24
EP2531178B1 (de) 2014-06-04
WO2011095269A2 (de) 2011-08-11
DK2531178T3 (da) 2014-09-01
WO2011095269A3 (de) 2012-05-18
JP5926195B2 (ja) 2016-05-25
JP2013518833A (ja) 2013-05-23

Similar Documents

Publication Publication Date Title
ES2497574T3 (es) Hidróxido carbonato de magnesio directamente compresible
NZ611467A (en) Rapidly dispersing granules, orally disintegrating tablets and methods
TR201816462T4 (tr) Doğrudan preslenebilir polivinil alkoller.
BRPI0709847B8 (pt) composição farmacêutica sólida de liberação rápida contendo paracetamol e carbonato de cálcio
MX2013014788A (es) Liberacion modificada de 4-metil-3-[[4-(3-piridinl)-2-pirimidinil] -amino]-n-[5-(4-metil-1h-imidazol-1-il)-3-(trifluoro-metil)-fenil ]-benzamida solubilizada utilizando acidos organicos.
CO6280463A2 (es) Formulaciones farmaceuticas solidas que comprenden bibw 2992
PH12019500610A1 (en) Controlled release tablet based on polyvinyl alcohol and its manufacturing
MY145089A (en) Pharmaceutical composition
SG196810A1 (en) Controlled release pharmaceutical or foodformulation and process for its preparation
MX2008011579A (es) Forma galenica divisible que permite una liberacion modificada del principio activo.
MX2016009719A (es) Sistema dispensador para productos de papel sanitario.
RU2012113740A (ru) Антацидная и слабительная таблетка
ES2623025T3 (es) Comprimido de desintegración oral que contiene acarbosa
AR116461A1 (es) Excipiente de alto rendimiento que comprende celulosa microcristalina co-procesada y carbonato de calcio reaccionado en superficie
IL179601A0 (en) Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active susbtance
JP6244363B2 (ja) 有効成分を含有する製剤における担体材料としての水酸化炭酸マグネシウム
PE20110706A1 (es) Uso de dronedarona para la preparacion de un medicamento para la prevencion de ictus o ataque isquemico transitorio
CL2008003438A1 (es) Producto liquido nutricional de administracion oral que comprende un antagonista del receptor vanilloide 1 (vr-1) y su uso para tratar la disfagia oral faringea.
RU2011147183A (ru) Таблетка и пестик для нее
MY170470A (en) Magnesium hydroxide particle and resin composition comprising the same
PE20110119A1 (es) Asociacion entre ferroquina y artesunato para el tratamiento del paludismo
CO6321152A2 (es) Matriz de comprimidos de compresion directa y rapida desintegracion
RU2009118826A (ru) Эсциталопрам и твердая фармацевтическая композиция, его содержащая
WO2015023631A3 (en) Fatty acid analogs and their use
PH12019500662A1 (en) Instant release capsule based on hot melt extruded polyvinyl alcohol